What destroys the joint in rheumatoid arthritis?

被引:20
作者
Fassbender, HG [1 ]
机构
[1] WHO Ctr, Zentrum Rheumapathol, D-55116 Mainz, Germany
关键词
D O I
10.1007/BF00703430
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
The immunological disturbance in rheumatoid arthritis (RA) gives rise to a nonspecific inflammatory reaction mediated by cells and cytokines. This immunological nonbacterial synovitis, however, does not destroy the articular cartilage. The destruction of joint structures is the effect of tumor-like aggressive synoviogenic cell elements (TLP). These TLP formations are not observed in any other type of arthritis. TLP formations are strictly avascular and short-lived. After they have decayed, a collagenous pannus remains. Invasion and destruction of joint structures are brought about by several types of proteases, synthesized and secreted by highly active TLP cells. The TLP formations possess more than twice the affinity for adjacent bone than for the articular cartilage. In these formations, four oncogenes could be identified. In the course of RA disease, TLP formations can recur. Thus, the joint damage can summate with time. The oncological character of the aggressive process in RA demands new therapeutical considerations to protect RA patients from destruction of their joints.
引用
收藏
页码:2 / 7
页数:6
相关论文
共 27 条
[1]   MONOARTICULAR ARTHRITIS IN CHILDREN [J].
BYWATERS, EG ;
ANSELL, BM .
ANNALS OF THE RHEUMATIC DISEASES, 1965, 24 (02) :116-&
[2]  
CASE JP, 1989, AM J PATHOL, V135, P1055
[3]  
ERMIS A, 1994, VERH DEUT G, V78, P650
[4]  
Fassbender H G, 1980, Verh Dtsch Ges Pathol, V64, P193
[5]   EXTRA-ARTICULAR PROCESSES IN OSTEOARTHROPATHIA PSORIATICA [J].
FASSBENDER, HG .
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 1979, 95 (1-2) :37-46
[6]   PATHWAYS OF DESTRUCTION IN METACARPAL AND METATARSAL JOINTS OF PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
FASSBENDER, HG ;
SEIBEL, M ;
HEBERT, T .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1992, 21 (01) :10-16
[7]  
FASSBENDER HG, 1986, ARTHRITIS SPONDYLITI, P31
[8]  
FASSBENDER HG, 1973, THERAPIEWOCHE, V23, P611
[9]  
Fidler I J, 1978, Adv Cancer Res, V28, P149, DOI 10.1016/S0065-230X(08)60648-X
[10]  
FIRESTEIN GS, 1990, J IMMUNOL, V144, P3347